Background. Our study evaluated correlates of human immunodeficiency virus (HIV)-1 lesional shedding among men with genital ulcer disease (GUD).
3
. Overall, 173 (45.6%) had detectable HIV-1 RNA in ulcers. Men with Trichomonas vaginalis infection had higher ulcer viral loads on average than did those who were not infected (mean difference, 0.62; 95% confidence interval [CI] , 0.07-1.2;
). After multivariable analysis, higher plasma HIV-1 load (odds P p .027 ratio [OR], 2.5; 95% CI, 1.7-3.5;
), larger lesions (OR, 2.5; 95% CI, 1.5-4.1; ), purulent ulcers P ! .001 P ! .001 (OR, 2.2; 95% CI, 1.1-4.2;
), multiple ulcers (15; OR, 3.6; 95% CI, 1.6-8.4; ), and herpes P p .02 P p .002 seropositivity (OR, 3.4; 95% CI, 1.7-7.0; ) remained associated with increased odds of HIV-1 lesional P ! .001 shedding. Ulcers associated with herpes simplex virus type 2 infection were less likely to shed (OR, 0.6; 95% CI, 0.3-1.0;
), compared with ulcers with unknown etiology. P p .05 Conclusions. HIV-positive men should be screened and treated for GUD to minimize HIV shedding and transmission to uninfected sexual partners.
Several studies have identified higher relative risks of human immunodeficiency virus (HIV) infection associated with genital ulcer disease (GUD) compared to other sexually transmitted infections [1] [2] [3] . There are several mechanisms whereby GUD-causing agents are thought to influence HIV infection. The ulcer itself provides a portal of entry so that GUD could facilitate acquisition of HIV [4] . In addition, inflammation caused by GUD pathogens recruits CD4 T cells and other immune cells that serve as target cells for HIV infection [5] [6] [7] .
The presence of HIV in the ulcer may also facilitate HIV transmission between discordant sexual partners. HIV has been detected in 11%-34% of genital ulcers [8] [9] [10] . The Rakai study of HIV-discordant, monogamous couples found that the 2 most important risk factors for HIV transmission were the presence of genital ulcers and high plasma HIV-1 loads [11, 12] .
Genital herpes simplex virus type 2 (HSV-2) infection is the leading cause of GUD on a global level. Both symptomatic and asymptomatic recurrences of HSV-2 infection have been shown to enhance HIV-1 shedding among persons with coinfection [13] [14] [15] . HSV-2 increases the likelihood of HIV acquisition, but suppression of HSV-2 reactivation with systemic antiviral drugs was not found to reduce HIV infection in controlled trials [16] [17] [18] . An in situ study of sequential biopsy specimens from HSV-2 lesions obtained from partici-pants who were receiving or not receiving antiviral therapy offered a possible explanation for these findings [19] . The study found that HSV-2 infection results in a profound, persistent localized inflammatory response in the dermis below the healed lesion, consisting of HSV-2-specific CD4 + T cells that express CCR5 or CXCR4, which are important HIV coreceptors. Even prolonged HSV-2 antiviral therapy did not significantly influence the composition of this infiltrate, suggesting that the increased susceptibility to HIV infection among HSV-2-infected individuals would not modified by antiherpetic therapy [19] .
We evaluated HIV-1 and HSV-2 shedding among men with genital ulcers in South Africa to investigate correlates of HIV-1 shedding and the association between HSV-2 and HIV-1 ulcer shedding.
PARTICIPANTS AND METHODS
This study was performed as secondary analysis of an individually randomized, double-blind placebo-control trial of the addition of acyclovir to routine syndromic management for GUD among men in South Africa (Clinicaltrials.gov identifier NCT00164424) done in 2005-2006 [20] . After informed consent, men with genital ulcers were enrolled in the trial. This analysis includes all HIV-positive participants at baseline. A questionnaire was administered to collect information on demographics, sexual behavior and clinical characteristics of the ulcers. All participants received single-dose antibiotic therapy for GUD following syndromic management guidelines with benzathine penicillin (2.4 MU intramuscularly) and ciprofloxacin (500 mg orally). Treatment was provided to those with other sexually transmitted infection symptoms or a laboratory diagnosed non-ulcerative sexually transmitted infection. HIVpositive participants were referred for appropriate care to antiretroviral therapy clinics.
Specimen collection. Among the first 85 participants, a pilot was conducted to compare swabs and lavages for the detection and quantitation of HIV-1 RNA in genital ulcers. There was no difference between the lavage and swabs in the ability to detect and quantify HIV-1 RNA. Lavages were chosen as the sampling method for the remainder of the study because they allowed collection of a more standardized volume of secretions, covered all ulcers present, and were less likely to induce bleeding [21] . Ulcer samples were collected consistently in the following order: (1) lavage for HIV-1 RNA level quantification, (2) swab for HSV-2 DNA level quantification, and (3) swab for ulcer etiology. Ulcer lavages were performed through a non-traumatic washing with 10 mL of phosphate-buffered saline (pH, 7.2) [20, 21] . The phosphate-buffered saline was gently squirted into the ulcer with a syringe and collected into a sterile container. To collect ulcer swabs, a sterile dry swab was gently applied on the ulcer base, and slight pressure was applied by partly rotating the swab while avoiding mucosal trauma. This procedure was repeated twice. Samples were stored dry at Ϫ70ЊC until tested. First-catch urine for detection of urethritis pathogens and blood samples for plasma viral load and serological testing were also obtained.
HIV and sexually transmitted infection screening. HIV testing was done on site with 2 rapid HIV tests (Determine [Abbott Laboratories] and Capillus [Trinity Biotech]). CD4 + cell counts were determined by standard flow cytometry methodology using a FACScan flow cytometer (Becton Dickinson Immunocytometry Systems). The patients' serum specimens were tested for syphilis seroreactivity by both rapid plasma reagin (Macro-Vue RPR; Becton Dickinson) and Treponema pallidum passive particle-agglutination assay (TPPA; Fujirebio) and for HSV-2 type-specific antibody by enzyme-linked immunosorbent assay (Kalon Biological). Detection of Chlamydia trachomatis, Neisseria gonorrheae, Mycoplasma genitalium, and Trichomonas vaginalis in urine samples was done using realtime multiplex polymerase chain reaction (M-PCR). Ulcer etiology was determined using a M-PCR assay [22] for the detection of T. pallidum, Haemophilus ducreyi, and HSV (type 1 or 2), and a separate PCR assay was used for detection of C. trachomatis L1-L3 [23] . All real-time PCR assays were in house assays that were run on a Rotor-Gene 3000 instrument (Corbett Robotics).
Quantification of viral shedding. Plasma HIV-1 loads were measured using the Amplicor HIV-1 monitor test, version 1.5 (Roche Diagnostics System). The lower limit for the Amplicor HIV-1 test was 400 copies/mL, and the upper limit was 750,000 copies/mL. A different assay was used to measure HIV-1 RNA shedding from ulcer lavages to increase sensitivity, the HIV-1 Amplicor 1.5 Ultra Sensitive Assay (Roche Diagnostics System). In brief, 750 mL of ulcer lavage was initially centrifuged (23,000g for 1 h at 5ЊC), and 250 mL of the supernatant was removed, replaced with normal human plasma, and vortexed. The total RNA was extracted from the lavage-plasma mixture in the normal manner. The lower and upper limits of detection are 50 and 100,000 copies/mL, respectively.
Amplification and quantification of the HSV-2 DNA shedding from ulcers swabs was achieved using a specific in-house duplex real-time PCR assay targeting the HSV glycoprotein G. The HSV-2 amplification assay has been validated against known HSV-1 and HSV-2 strains, and the HSV-2 primers and probes do not amplify HSV-1 DNA [24] . The level of HSV-2 DNA was calculated on the basis of a standard curve generated by amplification of serial dilutions of HSV-2 strain G quantitated DNA from 10 4 to 10 copies/reaction (Advanced Biotechnologies). The lower limit of detection for this assay was determined to be ∼10 genomic copies per reaction or 1000 copies/ mL. Serial dilutions of the quantitated HSV DNA were generated for each quantification assay of unknown specimens and tested in duplicate to generate standard curves with slopes be- tween -3.2 and -3.4. Specimen data were plotted on the standard curve, and the level of HSV-2 was calculated from duplicate runs of each specimen. The HSV-2 load was reported as the number of copies per milliliter on the basis of the original resuspension of the swabs in GeneLock (Sierra Molecular). All assays were run on the Rotor-Gene 3000 instrument (Corbett Research). Statistical analysis. We conducted exploratory analysis to investigate variables associated with the presence and quantity of HIV-1 in genital lesions to identify individuals that might be more infectious for HIV. The association of HIV-1 and HSV-2 in lesions was further explored among dually infected individuals (infected defined as being sero-positive or having virus isolated from the lesion), and the correlation between the viruses in the lesions and with HIV-1 in plasma and CD4 + cell count was analyzed.
To evaluate the associations between demographic, behavioral, clinical, and biological variables, the outcome variable, HIV-1 RNA detection in ulcers, was dichotomized as virus present (150 copies/mL) or no virus present or undetectable (р50 copies/ mL). Tests of independence between 2 categorical variables were performed using the x 2 statistic. Associations between ulcer HIV-1 loads and related factors were summarized with odds ratios (ORs) and 95% confidence intervals (CIs). Continuous variables were presented as medians with interquartile ranges, and 2-sample t-tests were used when comparing the means between two groups. When estimating the means and 95% confidence intervals for plasma and ulcer HIV-1 viral loads both were treated as censored variables. Censored variables are those for which the actual value is not observed but rather simply known to be less than some value defined by the measurement limits. Plasma HIV-1 load was left censored at 400 copies/mL and right censored at 750,000 copies/mL, whereas, ulcer HIV-1 load was left censored at the limit of detection, 50 copies/mL. Censored variables were + cell count (B) was the correlation was Ϫ0.20 ( ). The P p .001 distribution of log plasma HIV-1 load and CD4 + cell counts among those who have nondetectable HIV-1 ulcer shedding is displayed as box plots.
analyzed using maximum likelihood estimation methods, assuming a log normal distribution of the data [17] . The correlation coefficient between the continuous censored variables was estimated using maximum likelihood methods, assuming a bivariate normal likelihood as described in Lyles et al [18, 19] . Multiple logistic regression was used to adjust the associations for plasma HIV-1 load and other covariates. All variables associated with the outcome with a P value !.10 in univariate analysis were initially included in the model and retained if they remained statistically significant at . Pair-wise interactions between P ! .05 the variables selected for the final model were investigated.
The study received ethical approval from University of the Witwatersrand, London School of Hygiene and Tropical Medicine, the US Centers for Disease Control and Prevention, the Gauteng Provincial and City of Johannesburg Departments of Health, and the City of Tshwane Metropolitan Municipality.
RESULTS
A total of 387 HIV-positive men with genital ulcers were included in this study (Table 1) . HSV was detected in 76.2% of ulcers (including mixed infections); mean HSV-2 load in ulcers was 5.56 log copies/mL (95% CI, 5.33-5.80). There were 54 cases of initial episodes of genital herpes (defined by laboratory findings as HSV-2 seronegative with HSV-2 isolated from the ulcer ). Men with initial herpes shed higher quantities of P p .001 HSV-2 (mean, 6.06 log 10 copies/mL; 95% CI, 5.53-6.58 log 10 copies/mL) than did those with recurrent herpes (mean, 4.45 log 10 copies/mL; 95% CI, 4.19-4.71 log 10 copies/mL; ). P ! .001 Determinants of HIV-1 shedding in lesions. Ulcer specimens for HIV-1 detection were collected from 379 of 387 HIV-1-infected men; of these, 173 (45.6%) had detectable HIV-1 RNA. The mean HIV-1 log viral load in lesions was 1.58 log 10 copies/mL (95% CI, 1.36-1.79 log 10 copies/mL). Four of 9 antiretroviral-treated participants and 1 of the 9 men with undetectable plasma viral loads had detectable lesional HIV-1 levels.
Mean plasma HIV-1 loads were 0.44 log copies/mL (95% CI, 0.27-0.61 log copies/mL) higher among men with detectable HIV-1 in lesions than in those without HIV-1 in lesions (P ! ). Lesional HIV-1 RNA was positively correlated with .001 plasma HIV-1 ( ; ) and negatively with CD4 + R p 0.37 P ! .001 cell count ( ; ) (Figure 1 ). R p Ϫ0.20 P ! .001 In unadjusted analyses ( (Table 2 ). When eval-P ! .001 uating ulcer HIV-1 loads as a continuous variable, we confirmed the significant associations, as presented in Table 2 , with the exception of T. vaginalis. Men with T. vaginalis infection had higher viral loads on average than did those who were not infected (mean difference, 0.62; 95% CI, 0.07-1.2; ). P p .027 After multivariable analysis (Table 3) , plasma HIV-1 load (OR, 2.5; 95% CI, 1.7-3.5;
), larger lesions (OR, 2.5; P ! .001 95% CI, 1.5-4.2;
), purulent ulcers (OR, 2.2; 95% CI, P ! .001 1.1-4.2; P p .02), multiple (15) lesions (OR, 3.6; 95% CI, 1.6-8.4; ), and positive HSV-2 serologic test results (OR, P p .002 3.4; 95% CI, 1.7-7.0; ) remained associated with in-P ! .001 creased odds of HIV-1 lesional shedding. Ulcers due to HSV had less HIV-1 shedding (OR, 0.6; 95% CI, 0.3-1.0; ), P p .05 compared with ulcers with unknown etiology. There was a statistically significant interaction between herpes serology and ulcer etiology. The interaction showed that HSV-2 seropositivity only influenced HIV-1 shedding among those with HSV in the ulcer (OR, 6.2; 95% CI, 2.5-15.4;
) but had no effect P ! .001 among those with unknown etiology (OR, 0.4; 95% CI, 0.1-2.8; P p .38) or with bacterial or mixed etiology (OR, 0.6; 95% CI, 0.03-11.3; P p .70). The interaction further suggested that men with recurrent herpes (HSV-2 in the ulcer and seropositive for HSV-2) had increased HIV-1 shedding, compared with men who had initial episodes of genital herpes (HSV-2 in the ulcer but HSV-2 seronegative).
Relation between HSV-2 and HIV-1. Among 375 coinfected men with HIV and HSV-2 (HSV-2 seropositive or HSV-2 in the ulcer), there was no correlation between HSV-2 DNA and HIV-1 RNA in lesions (R p 0.001; P p .99), plasma HIV-1 loads (R p 0.03; P p .56), or CD4 + cell counts (R p Ϫ0.01; P p .84). However, when restricting the analysis to men with HIV-1 RNA present in lesions, there was a significant positive correlation between HSV-2 loads in ulcers and HIV-1 shedding in ulcers (R p 0.17; P p .02) and plasma HIV-1 load (R p 0.21; P ! .01) and a negative correlation with CD4 + cell counts (R p Ϫ0.20; P p .01).
DISCUSSION
This study evaluated variables associated with HIV-1 lesional shedding and the association between HSV-2 and HIV-1 shedding. We found that men with larger lesions, purulent and multiple ulcers, higher plasma viral loads, and HSV-2 seropositivity were at increased odds of HIV-1 shedding after adjusting for other factors. We also found that men infected with T. vaginalis had higher ulcer HIV-1 loads, although this association was not present when evaluating HIV shedding as a dichotomous variable. This study documented very few ulcers caused by the 'classic' bacterial etiologies of GUD (syphilis and chancroid), which confirmed the trend already reported in previous studies [25] and the importance of genital herpes as the dominant etiology of genital ulcer disease in African patients [26] [27] [28] .
Ulcers of unknown etiology were more likely to shed HIV-1 than herpetic ulcers. Given that HSV-2 was the leading cause of the genital ulcers in this study, it is likely that several of the ulcers of unknown etiology were also herpetic in origin. Molecular diagnostic tests for GUD pathogens may be negative when specimens are poorly taken, taken from partially healed ulcers, when pathogen DNA is present in small copy number, as well as due to suboptimal storage and/or DNA degradation from repeated freeze-thaw cycles in the laboratory. Acute HIV infection may also be a rare cause of genital ulceration [29] [30] [31] [32] . The lack of a significant immune response in acute HIV infection could possibly explain the increased HIV shedding among the unknown etiology group when compared to ulcers due to HSV [10] . Supporting this hypothesis, a separate analysis in which we investigated acute HIV-1 among HIV-seronegative individuals with genital ulcerations, found an association between ulcers of unknown etiology and acute HIV-1 infection (Paz-Bailey et al; unpublished data).
HSV-2 loads in ulcers were positively correlated with HIV-1 loads in lesions and in plasma and negatively with CD4 + cell counts, when evaluating men with detectable HIV-1 in lesions. Although there are no other published data on the association between HIV-1 and HSV-2 in genital ulcers, Legoff et al [33] evaluated the association between both viruses among women with genital ulcers using both ulcer swabs and cervicovaginal lavage specimens. The study found an association between HSV-2 and HIV-1 when pooling data on shedding from cervicovaginal lavage and genital ulcerations. Most previous studies looking at vaginal and cervical HIV-1 and HSV-2 shedding (mainly asymptomatic participants without genital ulcerations) have found an association between the viruses when analyzing subgroups such as HSV-2 shedders or dual HIV-1/HSV-2 shedders [13] [14] [15] 34] .
Herpes serology was only associated with increased HIV-1 shedding among herpetic ulcers but not among men with ulcers due to bacterial/mixed etiologies or with unknown etiology. Among those with HSV in the ulcer, the interaction showed that men with recurrent herpes had increased HIV-1 genital shedding, compared with those with initial episodes of genital herpes. Although the interaction, at first glance, may seem counterintuitive, because patients with initial herpes have more dramatic manifestations with larger ulcers that last longer [35, 36] , our data show that-in addition to systemic factors, such as herpes seropositivity and plasma HIV-1 load-the ulcer symptoms are the most important drivers of HIV-1 shedding (larger, purulent, and multiple ulcers). These findings could be relevant in clinical practice to identify individuals that are more likely to be shedding HIV-1. Previous studies have suggested that T. vaginalis is associated with increased susceptibility to HIV infection [37] [38] [39] [40] . Our findings support the hypothesis that individuals coinfected with HIV and T. vaginalis are also more infectious.
There were some limitations to this study. This was a crosssectional analysis and the associations found do not imply causality. This study did not measure HIV-1 DNA to determine its relative contribution to the viral nucleic acids quantified. These specimens were collected from genital ulcers only rather than a combination of genital ulcer and internal genital tract (ie, semen); this may have led us to underestimate the effect of GUD on overall HIV shedding. Viral presence in the lesions may be more susceptible to the presence of other infectious agents, the effect of treatment, duration of the lesion before entering the study and other factors that could not be controlled for in the study design and data analysis. Our study showed the presence of lesional HIV-1 in almost one-half of the HIV-positive men, which underscores the importance of GUD on increasing HIV-1 infectivity. There is a need to intensify and expand access to HIV voluntary counseling, testing, and referral for antiretroviral therapy in settings where patients with sexually transmitted infections are treated. The findings from this and other studies suggest that patients with genital ulcers are a key population to intervene for HIV prevention.
